Table of Contents Table of Contents
Previous Page  346 / 398 Next Page
Information
Show Menu
Previous Page 346 / 398 Next Page
Page Background

341

Research and New Technologies

New strategy for benign parotid surgery

M. Adachi

∗

, K. Ijichi, Y. Ehara, Y. Takai, S. Sumitomo

Department of Oral and Maxillofacial Surgery, Asahi

University, School of Dentistry, Mizuho, Gifu, Japan

Background:

A bayonet-shaped incision called a Blair incision

has been usedwidely for parotid grand surgerywithout reconstruc-

tion of the parotid-bed. However, this approach shows obvious

cervical scar on the neck. Parotid gland surgery exposes patients

to a variable risk of facial nerve palsy and gustatory sweating of

the cheek (Frey syndrome).

Objectives:

To achieve a better cosmetic result and preserve the

facial nerve function. We used face-lift approach and the skin flap

was elevated above superficial musculoaponeurotic system access

to the parotid gland, then we performed continuous facial nerve

monitoring provided by nerve integrity monitor (NIM) to avoid

facial nerve complications.

Methods:

We performed surgical treatment for the patient with

Warthin’s tumour at the deep lobe of parotid grand under gen-

eral anaesthesia. The modified facelift incision was started from

preauricular to infra-earlobe, and the retroauricular region then

extended to postauricular hair parallel to the hairline. The skin

flap was raised with subcutaneous fat prior to parotidectomy. The

parotidectomy was performed with NIM

®

3.0 and 2 detection

channels were used with the electrodes placed into the orbicu-

laris oculi and orbicularis oris muscles. We appropriately used a

stimulation probe was used during surgery to explore the facial

nerve branches.

Findings:

There was no complication during this operation or

after surgery including facial nerve palsy and Frey’s syndrome.

Also, the patient satisfied with the aesthetic outcome.

Conclusion:

Using a combination of the face-lift approach and

facial nerve identification with NIM represents a cosmetic and

safe strategy for parotid gland surgery.

http://dx.doi.org/10.1016/j.ijom.2017.02.1148

Three-dimensional printing in oral and maxillofacial surgery

Z. Ahmad

∗

, E. Austin, M. Bajalan

Kings College, School of Dentistry, London, United Kingdom

Background:

The use of three-dimensional printing (3D) appli-

cation technology continues to shine in oral and maxillofacial

surgery. Current applications of in maxillofacial surgery include

trauma surgery, pathology induced defects, tissue engineering,

complex temporomandibular joint reconstruction and correction

of complicated facial asymmetry.

Objective:

The aims of this study were to review the current meth-

ods of 3D printing in the literature and explore their application

in oral and maxillofacial surgery.

Methods:

A PubMed search was performed to review current

methods of 3D printing within surgery and to look at their merits

and pitfalls. Their use within facial surgery was then noted.

Findings:

We found there were three types of technology mainly

used in surgical 3D printing. The main use within facial surgery

included 3D reconstruction planning, custom implants and novel

tissue engineering.

Conclusion:

3D printing technology in surgery has advanced

greatly since its infancy in 1994. Its use within maxillofacial

surgery continues to show growth and exciting prospect.

http://dx.doi.org/10.1016/j.ijom.2017.02.1149

Predicting temporal artery biopsy results

. . .

offering

insights into temporal arteritis

T. Ali

∗

, A. McCabe, A. Ahluwalia, K. Fairburn, M. Racey,

G. Jutley

Aintree University Hospital, Liverpool, United Kingdom

Background:

Besides a significant false negative rate, temporal

artery biopsy has a small risk of significant complications includ-

ing facial nerve injury, scalp necrosis and stroke. The procedure

may be contraindicated by patient’s wishes or bleeding diathesis.

Objectives:

To study the incidence of biopsy-proven temporal

arteritis in the population surrounding Chesterfield Royal Hospi-

tal, United Kingdom.

Methods:

A retrospective review of 235 consecutive patients who

underwent a temporal artery biopsy from 2009 to 2015. Study

variables included age at diagnosis, gender, C-reactive protein,

erythrocyte sedimentation rate (ESR) and alkaline phosphatase

results prior to treatment.

Results:

Among the 235 patients who underwent temporal artery

biopsy, the mean age of those in the biopsy-positive group, 76.4

years (95% CI 73.8, 79.0), was higher than that of those in the

biopsy-negative group, 70.4 (95%CI 69.0, 71.8). A logistic regres-

sion model showed there is a statistically significant increase in

the odds of a positive temporal artery biopsy of 1.072487 (CI,

1.03045–1.116238) for every year increase of age, in addition to

an odds increase of 1.022069 (CI 1.011327–1.032925) for every

1 mm/h increase in ESR.

Conclusions:

Our results show there is a significant increase of

likelihood of a positive temporal artery biopsy as the patient’s age

increases and the higher the value of ESR. Given a large enough

sample, these results suggest that a scoring system may be created

which can attempt to predict the likelihood of a positive temporal

artery biopsy. This may be useful for patients in which temporal

arteritis is suspected and biopsy is precluded.

http://dx.doi.org/10.1016/j.ijom.2017.02.1150

Cultured human periosteum-derived cells can differentiate

into osteoblasts in a peroxisome proliferator-activated

receptor gamma-mediated fashion via bone morphogenetic

protein signalling

J.H. Byun

∗

, J.E. Chung, Y.H. Kang, B.W. Park, Y.C. Cho,

I.Y. Sung

Department of Oral and Maxillofacial Surgery, Gyeongsang

National University School of Medicine, Jinju, South Korea

Background:

Peroxisome proliferator-activated receptor gamma

(PPAR ) is very specific to adipogenic differentiation and is

induced before transcriptional activation of most adipocyte genes.

PPAR is, therefore, well established as a prime regulator that

stimulates adipogenesis in multipotent mesenchymal stem cells.

However, the effects of PPAR agonists on the differentiation of

cultured osteoprecursor cells are still controversial.